Articles tagged with Deubiquitination
Researchers have uncovered how BAP1 functions at the molecular level and present a novel therapeutic strategy to slow cancer progression. BAP1's role in DNA repair pathways and its potential as a biomarker for personalized treatment are also explored.
A new study reveals how a promising Parkinson's drug works by inhibiting the enzyme USP30, which prevents damaged mitochondria from being degraded. This breakthrough could lead to targeted therapies for Parkinson's disease and chronic kidney disease.
Researchers have identified two new deubiquitinases, USP53 and USP54, which play a crucial role in removing polyubiquitin tags from proteins. This study suggests that mutations in the USP53 gene are associated with paediatric cholestasis, highlighting the potential for targeted treatment.